{"entity":{"id":"nct06872541","kind":"trial","name":"Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas","aka":[],"tldr":"A phase 2/3 trial in lung cancer, run by University of Sao Paulo, active but no longer recruiting.","summary":"Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas is a phase 2/3, interventional study registered as NCT06872541 by University of Sao Paulo, with a registry enrolment figure of 100 participants, started 2025-01-20 and due to reach its primary completion in 2026-10-20. Interventions recorded: Clopidogrel. Conditions listed: Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma. Primary outcome: Platelet Aggregation analyzed by optical aggregometry-ADP (AggRAM™- Helena Laboratories). Lung eligibility wording from the registry: \"* Confirmed diagnosis of non-small cell lung carcinoma in the case group; absence of history of any neoplasia for control group\". Sites: Brazil. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06872541","url":"https://clinicaltrials.gov/study/NCT06872541"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06872541","phase":"2/3","setting":"Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas","sponsor":"University of Sao Paulo","enrolled":100,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06872541/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}